Cargando…
The prognostic value of 18-FDG positron emission tomography in T cell non-Hodgkin lymphoma
Autores principales: | Eslick, R, Dunlop, L, Lin, M, Hsu, D, Ling, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436082/ https://www.ncbi.nlm.nih.gov/pubmed/28430171 http://dx.doi.org/10.1038/bcj.2017.39 |
Ejemplares similares
-
Role of (18)F-FDG Positron Emission Tomography/Computed Tomography Imaging in Testicular Lymphoma
por: Sahu, Kamal Kant, et al.
Publicado: (2019) -
Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Hodgkin's Lymphoma, COVID Vaccination, and Appropriate Investigation Time
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Utility of F-18 Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in a Patient Presenting with Acute Paraparesis in Detecting Isolated Relapse of Non-Hodgkin's Lymphoma Infiltrating the Spinal Cord
por: Jain, Tarun Kumar, et al.
Publicado: (2019) -
([18F])FDG Positron emission tomography with whole body magnetic resonance imaging (([18F])FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
por: Gallais Sérézal, I., et al.
Publicado: (2021) -
Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography
por: Kasamon, Yvette L.
Publicado: (2011)